Evidence map›Paper›PMID 24928616›Full record

ArticleBrain research2014

Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure.

Justin R Yates, Jennifer L Perry, Andrew C Meyer, Cassandra D Gipson, Richard Charnigo, Michael T Bardo

Abstract read
In one paragraph

Article in Brain research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Selective chemogenetic inactivation of corticoaccumbal projections disrupts trait choice impulsivity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  9. Article
  10. Article
  11. The effect of 5-HTThe journal of physiological sciences : JPS · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. 5-HTPsychopharmacology · 2018
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Justin R YatesDepartment of Psychology, University of Kentucky, Lexington, KY 40536, USA; Center for Drug Abuse Research Translation, University of Kentucky, Lexington, KY 40536, USA.
Jennifer L PerryDepartment of Psychology, Kalamazoo College, Kalamazoo, MI 49006, USA.
Andrew C MeyerDepartment of Psychiatry, University of Vermont, Burlington VT 05401, USA.
Cassandra D GipsonDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA.
Richard CharnigoDepartment of Biostatistics, University of Kentucky, Lexington, KY 40506, USA; Center for Drug Abuse Research Translation, University of Kentucky, Lexington, KY 40536, USA.
Michael T BardoDepartment of Psychology, University of Kentucky, Lexington, KY 40536, USA; Center for Drug Abuse Research Translation, University of Kentucky, Lexington, KY 40536, USA. Electronic address: mbardo@email.uky.edu.
University of Kentucky · USKalamazoo College · USMedical University of South Carolina · USUniversity of Vermont · US

Funding

Training and Pilot CoreP50DA005312 · NIDA · UNIVERSITY OF KENTUCKY · PI BARDO, MICHAEL T · 1987 to 2016
$19.5M
Training in Drug Abuse Related Research.T32DA016176 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2004 to 2020
$4.0M
RESEARCH TRAINING IN DRUG ABUSE BEHAVIORT32DA007304 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 1998 to 2012
$3.1M
NIDA NIH HHS P50 DA005312NIDA NIH HHS T32 DA007304NIDA NIH HHS T32 DA016176
6 · The paper itself

Abstract

Performance in an adjusting delay discounting procedure is predictive of drug abuse vulnerability; however, the shared underlying specific prefrontal neural systems linking delay discounting and increased addiction-like behaviors are unclear. Rats received direct infusions of methylphenidate (MPH; 6.25, 25.0, or 100μg), amphetamine (AMPH; 0.25, 1.0, or 4.0μg), or atomoxetine (ATO; 1.0, 4.0, or 16.0μg) into either medial prefrontal cortex (mPFC) or orbitofrontal cortex (OFC) immediately prior to performance in an adjusting delay task. These drugs were examined because they are efficacious in treating impulse control disorders. Because dopamine (DA) and serotonin (5-HT) receptors are implicated in impulsive behavior, separate groups of rats received microinfusions of the DA receptor-selective drugs SKF 81297 (0.1 or 0.4µg), SCH 23390 (0.25 or 1.0µg), quinpirole (1.25 or 5.0µg), and eticlopride (0.25 or 1.0µg), or received microinfusions of the 5-HT receptor-selective drugs 8-OH-DPAT (0.025 or 0.1μg), WAY 100635 (0.01 or 0.04μg), DOI (2.5 or 10.0μg), and ketanserin (0.1 or 0.4μg). Impulsive choice was not altered significantly by MPH, AMPH, or ATO into either mPFC or OFC, indicating that neither of these prefrontal regions alone may mediate the systemic effect of ADHD medications on impulsive choice. However, quinpriole (1.25μg) and eticlopride infused into mPFC increased impulsive choice, whereas 8-OH-DPAT infused into OFC decreased impulsive choice. These latter results demonstrate that blockade of DA D2 receptors in mPFC or activation of 5-HT1A receptors in OFC increases impulsive choice in the adjusting delay procedure.

Indexed as

Adrenergic Uptake InhibitorsAmphetamineAnimalsAtomoxetine HydrochlorideBehavior, AddictiveCentral Nervous System StimulantsChoice BehaviorDelay DiscountingDopamine AgentsDose-Response Relationship, DrugImpulsive BehaviorMaleMethylphenidatePrefrontal CortexPropylaminesRats, Sprague-DawleyAdrenergic Uptake InhibitorsAmphetamineAtomoxetine HydrochlorideCentral Nervous System StimulantsDopamine AgentsMethylphenidatePropylaminesReceptors, Dopamine D2Receptor, Serotonin, 5-HT1ASerotonin AgentsVesicular Monoamine Transport ProteinsAdjusting delay discountingDopamine receptorDopamine transporterNorepinephrine transporterRatSerotonin receptor

Identifiers

PMID24928616
PMCPMC4151178
OpenAlexW2058304697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.